Literature DB >> 12049970

Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations.

Sapna N Makhija1, Pradeep R Vavia.   

Abstract

A rapid, selective and stability indicating high performance liquid chromatographic method was developed and validated for the estimation of venlafaxine in pharmaceutical dosage forms. The analysis was done on a Spherisorb C8 (4.6 x 250 mm, 5 microm) column. The mobile phase consisted of acetonitrile:sodium dihydrogen orthophosphate [0.04 M], pH 6.8 (75:25) at a flow rate of 1.5 ml/min. Detection was carried out at a wavelength of 224 nm. The developed method was found to give good separation between the pure drug and the degraded product. The polynomial regression data for the calibration plots showed good linear relationship in the concentration range of 1-10 microg/ml with r=0.9999. The method was validated for precision, accuracy, ruggedness and recovery. The minimum detectable and minimum quantifiable amounts were found to be 150 and 600 ng/ml, respectively. The drug was stable under basic and oxidative conditions. However, the sample treated with acid showed an additional peak at a retention time of 4.32 min other than the main peak at a retention time of 5.32 min. Statistical analysis proves that the method is reproducible and selective for the estimation of venlafaxine. As the method could effectively separate the drug from the degradation product, it can be employed as a stability indicating one.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049970     DOI: 10.1016/s0731-7085(01)00701-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms.

Authors:  S L Baldania; K K Bhatt; R S Mehta; D A Shah; Tejal R Gandhi
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

2.  Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form.

Authors:  U K Chhalotiya; H B Patel; K K Bhatt
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

3.  Development and validation of stability indicating method for the quantitative determination of venlafaxine hydrochloride in extended release formulation using high performance liquid chromatography.

Authors:  Jaspreet Kaur; K K Srinivasan; Alex Joseph; Abhishek Gupta; Yogendra Singh; Kona S Srinivas; Garima Jain
Journal:  J Pharm Bioallied Sci       Date:  2010-01

4.  LC-UV and LC-MS evaluation of stress degradation behavior of desvenlafaxine.

Authors:  Shubhangi M Pawar; Laxman D Khatal; Satish Y Gabhe; Sunil R Dhaneshwar
Journal:  J Pharm Anal       Date:  2012-03-15

5.  Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Prazosin, Terazosin, and Doxazosin in Pharmaceutical Formulations.

Authors:  Alankar Shrivastava; Vipin B Gupta
Journal:  Sci Pharm       Date:  2012-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.